Patients with severe eczema who were treated with dupilumab experienced a reduction in symptoms and improved quality of life, according to a meta-analysis of several clinical trials published in JAMA Dermatology.
Oral vitamin D supplements reduced skin inflammation and increased immunoprotection in patients with chemical skin injuries, according to findings from a recent Northwestern Medicine clinical trial.
During a recent workshop, small groups of students met with multiple patients who live with dermatological conditions to learn advanced diagnosis skills.
Shiv Patel, a second-year medical student, was recently selected as a recipient of the Tylenol Future Care Scholarship, which recognizes 35 outstanding students nationwide pursuing healthcare degrees with scholarships totaling $250,000.
High doses of vitamin D alleviated symptoms for patients with toxic erythema of chemotherapy significantly faster than current treatments, according to a recent study.
Northwestern Medicine investigators have identified novel intracellular mechanisms that could serve as future therapeutic targets for inflammatory skin diseases.
The first biologic drug to treat moderate-to-severe eczema in infants and children was highly effective in reducing symptoms, according to a recent study.
A new study has identified a molecular switch, through a protein called CDK9, that plays an early and critical role in the skin stem cell differentiation process.
A new Northwestern Medicine study found of the new rules issued during a one-year period by the The Joint Commission, many did not appear to be supported by published evidence.
Rohail Memon, a second-year medical student, used his finance background to investigate the rise of private equity ownership in dermatology practice.